Insider · CIK 0001800670

Weber Barbara

Reports to the SEC for 4 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001800670

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-09	PBLSParabilis Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20.2K sh	—	—	20,215
2026-02-03	TNGXTango Therapeutics, Inc.S Sale	Director, Director, Executive Chair	SSale	−30.2K sh	$12.26	−$370K	1,629,587
2026-02-03	TNGXTango Therapeutics, Inc.S Sale	Director, Director, Executive Chair	SSale	−333 sh	$12.90	−$4,294.734	1,629,254
2026-02-02	TNGXTango Therapeutics, Inc.A Award	Director, Director, Executive Chair	AAward	+37.5K sh	—	—	1,659,773
2026-02-02	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Director, Executive Chair	AAward	+222K sh	—	—	222,132
2025-02-05	TNGXTango Therapeutics, Inc.S Sale	Director, Director, Executive Chair	SSale	−9,013 sh	$3.16	−$28.5K	1,622,251
2025-02-04	TNGXTango Therapeutics, Inc.S Sale	Director, Director, Executive Chair	SSale	−9,778 sh	$2.99	−$29.2K	1,631,264
2025-02-03	TNGXTango Therapeutics, Inc.A Award	Director, Director, Executive Chair	AAward	+106K sh	—	—	1,641,042
2025-02-03	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Director, Executive Chair	AAward	+635K sh	—	—	635,250
2024-10-08	RVMDRevolution Medicines, Inc.S Sale	Director	SSale	−5,200 sh	$48.02	−$250K	13,065
2024-08-21	RVMDRevolution Medicines, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−1,808 sh	$44.83	−$81.1K	18,265
2024-06-20	RVMDRevolution Medicines, Inc.A Award	Director	AAward	+4,800 sh	—	—	20,625
2024-06-20	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16.7K sh	—	—	16,700
2024-06-20	RVMDRevolution Medicines, Inc.A Award	Director	AAward	+4,248 sh	—	—	20,073
2024-06-20	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16K sh	—	—	15,955
2024-02-07	TNGXTango Therapeutics, Inc.S Sale	Director, Director, Executive Chair	SSale	−4,457 sh	$12.62	−$56.2K	1,535,167
2024-02-06	TNGXTango Therapeutics, Inc.S Sale	Director, Director, Executive Chair	SSale	−4,681 sh	$12.56	−$58.8K	1,539,624
2024-02-01	TNGXTango Therapeutics, Inc.A Award	Director, Director, Executive Chair	AAward	+87.2K sh	—	—	87,168
2024-02-01	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Director, Executive Chair	AAward	+523K sh	—	—	523,012
2023-09-01	RVMDRevolution Medicines, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,854 sh	$1.12	+$4,316.48	19,679
2023-09-01	RVMDRevolution Medicines, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+11.1K sh	$4.73	+$52.7K	30,825
2023-09-01	RVMDRevolution Medicines, Inc.S Sale	Director	SSale	−15K sh	$35.07	−$526K	15,825
2023-09-01	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,854 sh	—	—	9,635
2023-09-01	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−11.1K sh	—	—	1,851
2023-06-08	RVMDRevolution Medicines, Inc.A Award	Director	AAward	+5,200 sh	—	—	15,825
2023-06-08	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18.4K sh	—	—	18,400
2023-03-01	TNGXTango Therapeutics, Inc.A Award	Director, Director, Executive Chair	AAward	+89.5K sh	—	—	1,457,137
2023-03-01	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Director, Executive Chair	AAward	+537K sh	—	—	537,273
2022-06-16	RVMDRevolution Medicines, Inc.A Award	Director	AAward	+5,200 sh	—	—	10,625
2022-06-16	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18.4K sh	—	—	18,400
2022-02-01	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Director, Executive Chair	AAward	+625K sh	—	—	625,000
2021-08-12	TNGXTango Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Director, Executive Chair	AAward	+961K sh	—	—	961,403
2021-06-22	RVMDRevolution Medicines, Inc.A Award	Director	AAward	+3,617 sh	—	—	5,425
2021-06-22	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12.7K sh	—	—	12,659
2021-02-04	RVMDRevolution Medicines, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,000 sh	$4.73	+$23.7K	6,808
2021-02-04	RVMDRevolution Medicines, Inc.S Sale	Director	SSale	−4,100 sh	$50.02	−$205K	2,708
2021-02-04	RVMDRevolution Medicines, Inc.S Sale	Director	SSale	−900 sh	$51.86	−$46.7K	1,808
2021-02-04	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,000 sh	—	—	12,997
2021-02-02	RVMDRevolution Medicines, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,336 sh	$1.12	+$5,976.32	7,144
2021-02-02	RVMDRevolution Medicines, Inc.S Sale	Director	SSale	−5,336 sh	$45.00	−$240K	1,808
2021-02-02	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,336 sh	—	—	13,489
2020-12-30	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)J Other	Director	JOther	0 sh	—	—	18,825
2020-12-30	RVMDRevolution Medicines, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,336 sh	$1.12	+$5,976.32	7,144
2020-12-30	RVMDRevolution Medicines, Inc.S Sale	Director	SSale	−5,236 sh	$40.95	−$214K	1,908
2020-12-30	RVMDRevolution Medicines, Inc.S Sale	Director	SSale	−100 sh	$41.33	−$4,133	1,808
2020-12-30	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,336 sh	—	—	13,489
2020-10-05	RVMDRevolution Medicines, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+7,196 sh	$1.12	+$8,059.52	9,004
2020-10-05	RVMDRevolution Medicines, Inc.S Sale	Director	SSale	−7,196 sh	$36.17	−$260K	1,808
2020-10-05	RVMDRevolution Medicines, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,196 sh	—	—	18,825
2020-10-02	RVMDRevolution Medicines, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+804 sh	$1.12	+$900.48	2,612

Recent filings

Accepted (ET)
Jun 114
Weber Barbara0001193125-26-267802
SEC(opens sec.gov)
Feb 44
Weber Barbara0001193125-26-038070
SEC(opens sec.gov)
Feb 64
Weber Barbara0000950170-25-015684
SEC(opens sec.gov)
Feb 54
Weber Barbara0000950170-25-014810
SEC(opens sec.gov)
Oct 104
Weber Barbara0001610717-24-000504
SEC(opens sec.gov)
Aug 234
Weber Barbara0001610717-24-000443
SEC(opens sec.gov)
Jun 284/A
Weber Barbara0001610717-24-000377
SEC(opens sec.gov)
Jun 244
Weber Barbara0001610717-24-000358
SEC(opens sec.gov)
Feb 84
Weber Barbara0000950170-24-012999
SEC(opens sec.gov)
Feb 54
Weber Barbara0000950170-24-011253
SEC(opens sec.gov)
Sep 64
Weber Barbara0001610717-23-000260
SEC(opens sec.gov)

Companies

Address

C/O PARABILIS MEDICINES, INC. 30 ACORN PARK DRIVE, 6TH FLOOR

CAMBRIDGE, MA, 02140